Inger Therapeutics Private Limited

Inger Therapeutics Private Limited

Inger Therapeutics is a startup exploring various disease areas where Suprabodies can make a significant impact. The team is passionate about finding new ways to use Suprabodies to improve human health. 

Inspired from nature, the platform employs an unique ‘reshuffling’ during selection similar to antibodies, enabling the ability to evolve high affinity binders – Suprabodies. Inger Therapeutics is committed to using the platform to develop new ligands that enable Life science and Biotech companies globally.